JPRN-jRCT1040220135
Not yet recruiting
未知
Basic research on hyperpolarized MR imaging (DNP-MRI) using urologic cancer tissue
nakae Keita0 sites240 target enrollmentFebruary 6, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer, bladder cancer, kidney cancer
- Sponsor
- nakae Keita
- Enrollment
- 240
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients over 20 years of age with suspected prostate cancer or bladder cancer or renal cancer
- •(2\) Inpatients and outpatients
- •(3\) Patients who give written consent to participate in this study
Exclusion Criteria
- •(1\) Patients under 20 years old
- •2\) Patients with suspected prostate cancer but no prostate cancer is suspected by MRI scan.
- •3\) Patients with bladder cancer whose bladder cancer cannot be confirmed by the naked eye
- •(iv) Patients whose cancer is small and the collection of samples for the study may interfere with diagnosis and treatment.
- •(5\) Patients whose consent to participate in this study was not obtained in writing.
- •(iv) Patients who are judged to be ineligible for participation in this study by the principal investigator or subinvestigator of the medical institution where this study is conducted.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver DiseaseNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNon Alcoholic SteatohepatitisNAFLDNASHNCT06176079Michael Ohliger, MD PhD80
Terminated
Phase 1
Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate CancerProstate CancerNCT02911467Rahul Aggarwal8
Recruiting
Phase 2
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate CancerProstate CancerAdvanced Prostate CarcinomaNCT04346225Ivan de Kouchkovsky, MD75
Recruiting
Phase 2
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human BodyHeart FailureCardiometabolic SyndromeCancer DiagnosisCardiovascular DiseasesHealthy VolunteersNCT06645691National Heart Centre Singapore200
Recruiting
Not Applicable
Development of Magnetic Resonance Imaging - Positron Emission Tomography (MRI-PET) Image Biomarkers for Brain Tumour Grading, Delineation and Measuring Early Treatment ResponseBrain TumourCancer - BrainACTRN12609000877280niversity of Queensland100